Sara Bindoli
Università degli Studi di Padova
H-index: 12
Europe-Italy
Top articles of Sara Bindoli
Diagnostic capabilities, clinical features, and longitudinal UBA1 clonal dynamics of a nationwide VEXAS cohort
American Journal of Hematology
2024/2
Correction: Clinical and laboratory features associated with macrophage activation syndrome in Still’s disease: data from the international AIDA Network Still’s Disease Registry
Internal and Emergency Medicine
2024/1
Paolo Sfriso
H-Index: 30
Lampros Fotis
H-Index: 8
Haner Direskeneli
H-Index: 39
Sara Bindoli
H-Index: 7
Fatma Alibaz-Oner
H-Index: 24
Joanna Makowska
H-Index: 9
Marcello Govoni
H-Index: 34
Giacomo Emmi
H-Index: 32
Maria Sole Chimenti
H-Index: 27
Benson Ogunjimi
H-Index: 16
Samar Tharwat
H-Index: 4
Alessandro Conforti
H-Index: 20
Alessandra Cartocci
H-Index: 5
Alberto Balistreri
H-Index: 3
Claudia Fabiani
H-Index: 14
Luca Cantarini
H-Index: 46
Pulmonary alveolar proteinosis in an adult patient affected by Still's disease and recurrent episodes of macrophage activation syndrome
Joint Bone Spine
2024
Orbital/ocular inflammatory involvement in VEXAS syndrome: Data from the international AIDA network VEXAS registry
Seminars in Arthritis and Rheumatism
2024/6/1
Adult-Onset Still’s Disease (AOSD): Advances in Understanding Pathophysiology, Genetics and Emerging Treatment Options
2024/3/5
Efficacy of canakinumab in patients with Still’s disease across different lines of biologic therapy: real-life data from the International AIDA Network Registry for Still’s Disease
Frontiers in Medicine
2023/12/12
Clinical and laboratory features associated with macrophage activation syndrome in Still’s disease: data from the international AIDA Network Still’s Disease Registry
Internal and Emergency Medicine
2023/11
Paolo Sfriso
H-Index: 30
Lampros Fotis
H-Index: 8
Haner Direskeneli
H-Index: 39
Sara Bindoli
H-Index: 7
Fatma Alibaz-Oner
H-Index: 24
Joanna Makowska
H-Index: 9
Marcello Govoni
H-Index: 34
Giacomo Emmi
H-Index: 32
Maria Sole Chimenti
H-Index: 27
Benson Ogunjimi
H-Index: 16
Samar Tharwat
H-Index: 4
Alessandro Conforti
H-Index: 20
Alessandra Cartocci
H-Index: 5
Alberto Balistreri
H-Index: 3
Claudia Fabiani
H-Index: 14
Luca Cantarini
H-Index: 46
P778: A CARTOGRAPHY OF UBA1 GENE TESTING, EPIDEMIOLOGY AND CLINICAL-GENOMIC CHARACTERISTICS: THE VEXAS ITALIAN EXPERIENCE
HemaSphere
2023/8/1
Autoinflammatory Diseases and COVID-19 Vaccination: Analysis of SARS-CoV-2 Anti-S-RBD IgG Levels in a Cohort of Patients Receiving IL-1 Inhibitors
Journal of Clinical Medicine
2023/7/18
IL-18 in Autoinflammatory Diseases: Focus on Adult Onset Still Disease and Macrophages Activation Syndrome
2023/7/5
AB1307 ANALYSIS OF ANTI-SARS-CoV-2 S-RBD IGG ANTIBODY LEVELS IN A COHORT OF PATIENTS RECEIVING IL-1 INHIBITORS
2023/6/1
POS1578 JAK INHIBITORS AND VEXAS SYNDROME: A SUCCESSFULLY CASE TREATED WITH FILGOTINIB
2023/6/1
Topic: AS01-Diagnosis/AS01c-Molecular aberrations (cytogenetic, genetic, gene expression): A CARTOGRAPHY OF UBA1 GENE TESTING, EPIDEMIOLOGY AND CLINICAL-GENOMIC CHARACTERISTICS …
Leukemia Research
2023/5/1
JAK inhibitors for the treatment of VEXAS syndrome
2023/3
Intravenous anakinra to curb cytokine storm in adult-onset Still's disease and in macrophage activation syndrome: a case series
Joint Bone Spine
2023/3/1
New onset and flare of rheumatic diseases following COVID-19 vaccination are mild and respond well to treatment: 9-month follow-up data from a single centre cohort
Clin Exp Rheumatol
2023/3
THE ADVANTAGES OF NEXT GENERATION SEQUENCING FOR CORRECTLY DIAGNOSING RARE RHEUMATIC AUTOINFLAMMATORY DISEASES: A SINGLE-CENTER STUDY
CLINICAL CHEMISTRY AND LABORATORY MEDICINE
2023
POS1278 EXCELLENT PROGNOSIS OF RHEUMATIC MANIFESTATIONS FOLLOWING COVID-19 VACCINATION: 7 MONTHS FOLLOW-UP DATA
2022/6/1
Progress in Biological Therapies for Adult-Onset Still’s Disease
2022/4/21
A pro-inflammatory signature constitutively activated in monogenic autoinflammatory diseases
International Journal of Molecular Sciences
2022/2/5
